Clinical Trial Update: A Study of A-101 Solution in Subjects With Common Warts. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of A-101 Solution for common warts has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Warts

Drugs mentioned

• A-101 Solution

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Common Warts | Phase 2 | Status: COMPLETED | Results posted: 2018-12-07